Literature DB >> 2236435

Effects of methylphenidate on processing negativities in patients with attention-deficit hyperactivity disorder.

R Klorman1, J T Brumaghim, L F Salzman, J Strauss, A D Borgstedt, M C McBride, S Loeb.   

Abstract

This study compared the impact of methylphenidate on patients with Attention-deficit Hyperactivity Disorder (ADHD) with and without aggressive/noncompliant features in an oddball test consisting of a randomly ordered series of loud (frequent) tones, soft (rare) tones, bright (frequent) lights, and dim (rare) lights. In alternate conditions, subjects were required to respond to either the rare tones or the rare lights. These tasks were administered in a drug-free baseline session and after a counterbalanced treatment of 14 days each of methylphenidate (0.3 mg/Kg b.i.d.) and placebo (lactose b.i.d.). In comparison with placebo, methylphenidate resulted in greater accuracy and speed of reactions to targets of both modalities. The amplitude of N1 to auditory nontargets was larger when the target was a rare tone as opposed to a rare light, and this attention-related effect was increased by methylphenidate. The same differential amplitude enhancement by stimulant treatment was found for an early area measure of difference ERPs. In contrast, for N1 to visual nontargets the effect of selective attention (larger amplitude when the target was a rare light vs. a rare tone) was not significant and was not affected by stimulant medication. All these findings were comparable for the three ADHD subgroups, a result attesting to the generality of stimulant effects on information processing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236435     DOI: 10.1111/j.1469-8986.1990.tb00391.x

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  5 in total

1.  Methylphenidate effects in attention deficit/hyperactivity disorder: electrodermal and ERP measures during a continuous performance task.

Authors:  Carlie A Lawrence; Robert J Barry; Adam R Clarke; Stuart J Johnstone; Rory McCarthy; Mark Selikowitz; Samantha J Broyd
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

2.  Mediators of psychosocial treatment for adolescent ADHD.

Authors:  Margaret H Sibley; Stefany J Coxe; Courtney Zulauf-McCurdy; Xin Zhao
Journal:  J Consult Clin Psychol       Date:  2022-07

3.  Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test.

Authors:  M N Verbaten; C C Overtoom; H S Koelega; H Swaab-Barneveld; R J van der Gaag; J Buitelaar; H van Engeland
Journal:  J Abnorm Child Psychol       Date:  1994-10

4.  Effects of Methylphenidate on Reaction Time in Children with Attention Deficit / Hyperactivity Disorder.

Authors:  Ayşegül Güven; Miray Altinkaynak; Nazan Dolu; Esra Demirci; Sevgi Özmen; Meltem İzzetoğlu; Ferhat Pektaş
Journal:  Noro Psikiyatr Ars       Date:  2018-04-20       Impact factor: 1.339

5.  Effects of methylphenidate on the ERP amplitude in youth with ADHD: A double-blind placebo-controlled cross-over EEG study.

Authors:  Mica Rubinson; Itai Horowitz; Jodie Naim-Feil; Doron Gothelf; Nava Levit-Binnun; Elisha Moses
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.